Does CYTARABINE Cause Progressive multifocal leukoencephalopathy? 146 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 146 reports of Progressive multifocal leukoencephalopathy have been filed in association with CYTARABINE (cytarabine). This represents 0.3% of all adverse event reports for CYTARABINE.
146
Reports of Progressive multifocal leukoencephalopathy with CYTARABINE
0.3%
of all CYTARABINE reports
94
Deaths
46
Hospitalizations
How Dangerous Is Progressive multifocal leukoencephalopathy From CYTARABINE?
Of the 146 reports, 94 (64.4%) resulted in death, 46 (31.5%) required hospitalization, and 10 (6.8%) were considered life-threatening.
Is Progressive multifocal leukoencephalopathy Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CYTARABINE. However, 146 reports have been filed with the FAERS database.
What Other Side Effects Does CYTARABINE Cause?
Febrile neutropenia (6,142)
Off label use (4,183)
Pyrexia (2,992)
Neutropenia (2,558)
Disease progression (2,352)
Drug ineffective (2,281)
Thrombocytopenia (2,148)
Sepsis (2,013)
Myelosuppression (1,869)
Product use in unapproved indication (1,619)
What Other Drugs Cause Progressive multifocal leukoencephalopathy?
NATALIZUMAB (1,668)
RITUXIMAB (1,647)
CYCLOPHOSPHAMIDE (782)
PREDNISONE (606)
PREDNISOLONE (439)
TACROLIMUS (438)
METHOTREXATE (428)
DOXORUBICIN (421)
MYCOPHENOLATE MOFETIL (414)
VINCRISTINE (376)
Which CYTARABINE Alternatives Have Lower Progressive multifocal leukoencephalopathy Risk?
CYTARABINE vs CYTARABINE\DAUNORUBICIN
CYTARABINE vs DABIGATRAN
CYTARABINE vs DABIGATRAN ETEXILATE
CYTARABINE vs DABRAFENIB
CYTARABINE vs DABRAFENIB\TRAMETINIB